Anhui Fengyuan Pharmaceutical Co., Ltd.
Symbole: 000153.SZ
SHZ
8.55
CNYPrix du marché aujourd'hui
17.7110
Ratio P/E
0.1358
Ratio PEG
2.84B
Cap MRK
- 0.01%
Rendement DIV
Anhui Fengyuan Pharmaceutical Co., Ltd. (000153-SZ) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1104.98 | 319.9 | 353.1 | 251.3 | |||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | -860.53 | -213.4 | 80.7 | -226.9 | |||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 4181.1 | 984.8 | 925.9 | 839.2 | |||||||||||||||||||||||||||
balance-sheet.row.inventory | 2298.35 | 573.6 | 699.1 | 569.5 | |||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 155.27 | 24.7 | 99.2 | 34.8 | |||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 7739.7 | 1902.9 | 2077.4 | 1694.8 | |||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 6019.73 | 1513.9 | 1461.7 | 1223.5 | |||||||||||||||||||||||||||
balance-sheet.row.goodwill | 31.68 | 7.9 | 7.9 | 7.9 | |||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1126.56 | 285.6 | 244.9 | 225.8 | |||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1158.24 | 293.5 | 252.8 | 233.7 | |||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2388.93 | 575.8 | 566.8 | 556.4 | |||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 213.4 | 60.2 | 40 | 37.5 | |||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 162.13 | 45 | 70.6 | 70.4 | |||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 9942.45 | 2488.4 | 2391.8 | 2121.6 | |||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.total-assets | 17682.15 | 4391.3 | 4469.2 | 3816.3 | |||||||||||||||||||||||||||
balance-sheet.row.account-payables | 2940.77 | 746.1 | 722.7 | 612.9 | |||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 2171.78 | 492.8 | 598.4 | 501.1 | |||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 201.48 | 49.9 | 68.1 | 43.5 | |||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 944.12 | 195 | 189.6 | 114 | |||||||||||||||||||||||||||
Deferred Revenue Non Current | 795.47 | 238 | 151.9 | 150.9 | |||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 104.89 | - | - | - | |||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 37.21 | 10.2 | 766.3 | 15.9 | |||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1844.48 | 458.9 | 369.8 | 338.2 | |||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 74.55 | 20.2 | 20.7 | 28 | |||||||||||||||||||||||||||
balance-sheet.row.total-liab | 10056.97 | 2472.5 | 2714.5 | 2258.6 | |||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.common-stock | 1328.27 | 332 | 332.1 | 312.1 | |||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 3532.26 | 888.7 | 764.4 | 629.3 | |||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 919.43 | 53.1 | 595.2 | 112.2 | |||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1733.96 | 615.5 | 36.8 | 474.6 | |||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 7513.92 | 1889.4 | 1728.5 | 1528.2 | |||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 17682.15 | 4391.3 | 4469.2 | 3816.3 | |||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 111.26 | 29.4 | 26.3 | 29.5 | |||||||||||||||||||||||||||
balance-sheet.row.total-equity | 7625.18 | 1918.8 | 1754.8 | 1557.7 | |||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 17682.15 | - | - | - | |||||||||||||||||||||||||||
Total Investments | 1528.4 | 362.4 | 371.5 | 329.5 | |||||||||||||||||||||||||||
balance-sheet.row.total-debt | 3115.9 | 687.8 | 788 | 615.1 | |||||||||||||||||||||||||||
balance-sheet.row.net-debt | 2010.92 | 367.9 | 434.8 | 363.8 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 160.27 | 150.9 | 109.5 | 102.1 | ||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 98.78 | 121.7 | 76.8 | 70.9 | ||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | -11.32 | -5.7 | -10.3 | 5.6 | ||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 18.88 | 5.7 | 10.3 | -5.6 | ||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -112.36 | 121.5 | -4.6 | 73.8 | ||||||||||||||||||||||||
cash-flows.row.account-receivables | -238.77 | -89.3 | -114.1 | 44.8 | ||||||||||||||||||||||||
cash-flows.row.inventory | 126.41 | -44.9 | -42.3 | -40.7 | ||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | 261.4 | 138.8 | -44.8 | ||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -5.7 | 12.9 | 114.5 | ||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 115.12 | 45.8 | 56.2 | 46 | ||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 250.48 | 0 | 0 | 0 | ||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -153.03 | -81.8 | -157.4 | -190.7 | ||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 7.94 | -302.7 | 1 | 4.3 | ||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -85 | -29 | -1 | -31.9 | ||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0.15 | 5.7 | 7.2 | 133.1 | ||||||||||||||||||||||||
cash-flows.row.other-investing-activites | -76.6 | 308.3 | 0.4 | 0.4 | ||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -229.62 | -99.4 | -149.7 | -84.9 | ||||||||||||||||||||||||
cash-flows.row.debt-repayment | -588.23 | -804.3 | -942.9 | -1157.2 | ||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.35 | 0 | 0 | 0 | ||||||||||||||||||||||||
cash-flows.row.dividends-paid | -62.48 | -57.5 | -25.6 | -38.4 | ||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 358.44 | 599.5 | 862.5 | 985.8 | ||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 55.59 | -262.3 | -106 | -209.8 | ||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.21 | 0.1 | -0.3 | -0.6 | ||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 76.66 | 78.4 | -18.2 | -2.5 | ||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1001.66 | 344.7 | 234.6 | 252.8 | ||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 925 | 266.3 | 252.8 | 255.3 | ||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 250.48 | 440 | 237.9 | 292.8 | ||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -153.03 | -81.8 | -157.4 | -190.7 | ||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 97.45 | 358.2 | 80.5 | 102 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 4189.99 | 4275.4 | 4004 | 3501.7 | |||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 3142.57 | 3176.3 | 2873.7 | 2447.4 | |||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 1047.42 | 1099.1 | 1130.3 | 1054.3 | |||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
income-statement-row.row.research-development | 64.97 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 34.67 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 543.4 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 1.43 | 1.6 | 117.7 | 103.7 | |||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 793.23 | 857.1 | 897.9 | 863.7 | |||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 3935.8 | 4033.4 | 3771.6 | 3311.1 | |||||||||||||||||||||||||||
income-statement-row.row.interest-income | 10.21 | 8.7 | 5.4 | 3.1 | |||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 31.84 | 33.9 | 32.9 | 38.6 | |||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 543.4 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 1.43 | 1.6 | 0.2 | 3.7 | |||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 1.43 | 1.6 | 117.7 | 103.7 | |||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 1.43 | 1.6 | 0.2 | 3.7 | |||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 31.84 | 33.9 | 32.9 | 38.6 | |||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 53.36 | 126.3 | 158.9 | 125.4 | |||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 267.41 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.operating-income | 214.06 | 213.3 | 202.1 | 146 | |||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 215.48 | 214.9 | 202.3 | 149.7 | |||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 57.47 | 57.6 | 51.4 | 40.3 | |||||||||||||||||||||||||||
income-statement-row.row.net-income | 160.27 | 159.3 | 154.4 | 123 |
Questions fréquemment posées
Quel est le total de Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ) de l'actif total?
Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ) Le total des actifs est 4391320148.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est 2172036791.000.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.250.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 0.294.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.038.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.051.
Qu'est-ce que Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 159285567.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 687763094.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 857067068.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 335906057.000.